Gradient Health aims to accelerate automated AI diagnostics by labeling the world’s medical imagery, one pathology at a time. It brings over 300 million medical images from around the world, labels them, and delivers them to healthcare A.I. companies and researchers.
“We’re excited to be working with world-class AI companies at the forefront of automated diagnostics,” Josh Miller, CEO of Gradient said. “VentureSouth’s investment in Gradient Health will allow us to continue building out our platform for ML and Research-ready healthcare data. We are happy to be growing Gradient with their support. We’re grateful to have VentureSouth in our corner once more.”
VentureSouth led the round and its members and funds invested nearly $1M into the company. We are excited to be working with frequent partners like the Charlotte Angel Fund and new co-investors including WaveMaker360, Bessemer’s Scout Fund, and Twenty5Twenty.
VentureSouth’s investment in Gradient included the first investment from the VentureSouth Angel Fund V sidecar fund, as well as the first funding into a Triangle-based company since the launch of VentureSouth Triangle in late 2021.
Paul Clark, Managing Director of VentureSouth, added: “VentureSouth members are grateful to Josh Miller and his team for a positive return on the first investment that we made with them. We are even more excited about the opportunity to invest again in a dynamic and proven team.”